Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for repetitive behaviours in children and adolescents with autism
ACTRN12608000173392Phase 2Completed
- Sponsor
- Victorian Medical Insurance Agency
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Children's Yale-Brown Obsessive Compulsive Scale total score. Started Nov 2010; status: completed.
02
Drugs
fluoxetine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12608000173392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000173392.